Literature DB >> 19200733

Immunomodulation of acute experimental spinal cord injury with human immunoglobulin G.

Beril Gok1, Daniel M Sciubba, Ozerk Okutan, Etem Beskonakli, Selcuk Palaoglu, Husamettin Erdamar, Mustafa F Sargon.   

Abstract

Immunomodulation of acute spinal cord injury may inhibit the activity of specific inflammatory cascades and result in recovery of motor function. In this study, evaluation of the protective effect of a well-known anti-inflammatory immunomodulator, immunoglobulin G (IgG), was conducted in rats after a 50 g/cm contusion spinal cord injury. Following injury, 400 mg/kg of IgG was administered to the treatment group. Twenty-four hours later, animals were assessed functionally via an inclined plane and the Basso-Beattie-Bresnahan motor scale and compared to controls. Tissue was reviewed for myeloperoxidase activiy (MPO) and lipid peroxidation (LPO), and electron microscopy was conducted to assess tissue ultrastructure. Significant functional preservation was observed in the IgG treatment group. In addition, biochemical assays revealed decreased MPO activity, and electron microscopic views of tissue showed preserved ultrastructure. IgG treatment following acute contusion injury to the rat spinal cord confers functional and structural neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200733     DOI: 10.1016/j.jocn.2008.04.024

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  8 in total

1.  High-dose IgG suppresses local inflammation and facilitates functional recovery after olfactory system injury.

Authors:  Kohei Nishida; Masayoshi Kobayashi; Eisuke Ishigami; Kazuhiko Takeuchi
Journal:  Ann Clin Transl Neurol       Date:  2022-05-19       Impact factor: 5.430

Review 2.  Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury.

Authors:  Michael G Fehlings; Dung H Nguyen
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

Review 3.  Hormonal therapy in traumatic spinal cord injury.

Authors:  Parker E Ludwig; Arun A Patil; Andrea J Chamczuk; Devendra K Agrawal
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

4.  Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury.

Authors:  Dung Hoang Nguyen; Newton Cho; Kajana Satkunendrarajah; James W Austin; Jian Wang; Michael G Fehlings
Journal:  J Neuroinflammation       Date:  2012-09-21       Impact factor: 8.322

Review 5.  Receptor for advanced glycation end products (RAGE) and its ligands: focus on spinal cord injury.

Authors:  Juhyun Song; Won Taek Lee; Kyung Ah Park; Jong Eun Lee
Journal:  Int J Mol Sci       Date:  2014-07-25       Impact factor: 5.923

Review 6.  Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury.

Authors:  Vivien Thom; Thiruma V Arumugam; Tim Magnus; Mathias Gelderblom
Journal:  Front Immunol       Date:  2017-07-31       Impact factor: 7.561

Review 7.  Treatment of spinal cord injury with intravenous immunoglobulin G: preliminary evidence and future perspectives.

Authors:  Apostolia Tzekou; Michael G Fehlings
Journal:  J Clin Immunol       Date:  2014-04-11       Impact factor: 8.317

Review 8.  Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury.

Authors:  Antigona Ulndreaj; Anna Badner; Michael G Fehlings
Journal:  F1000Res       Date:  2017-10-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.